Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Equity (2021 - 2026)

Rani Therapeutics Holdings' Return on Equity history spans 6 years, with the latest figure at 0.01% for Q1 2026.

  • On a quarterly basis, Return on Equity fell 60.0% to 0.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.01%, a 60.0% decrease, with the full-year FY2025 number at 0.02%, up 2.0% from a year prior.
  • Return on Equity came in at 0.01% for Q1 2026, up from 0.02% in the prior quarter.
  • The five-year high for Return on Equity was 0.59% in Q1 2025, with the low at 0.12% in Q4 2024.
  • Historically, Return on Equity has averaged 0.02% across 5 years, with a median of 0.01% in 2023.
  • Biggest five-year swings in Return on Equity: soared 62bps in 2025 and later plummeted -60bps in 2026.
  • Year by year, Return on Equity stood at 0.01% in 2022, then tumbled by -185bps to 0.02% in 2023, then tumbled by -442bps to 0.12% in 2024, then soared by 80bps to 0.02% in 2025, then skyrocketed by 61bps to 0.01% in 2026.
  • Business Quant data shows Return on Equity for RANI at 0.01% in Q1 2026, 0.02% in Q4 2025, and 0.06% in Q3 2025.